NR3C2 and metabolic dysfunction-associated steatohepatitis: The results suggest that NLRP3 inflammasome formation and activation via MR raft redox signaling platforms play a critical role in the initiation and progression of NASH and that FTZ exerts its beneficial action through inhibition of NLRP3 inflammasome activation in the liver.